SourceMedical's Therapy Software Partners with FOTO, the Leading Provider of Patient Outco...(d expand as requirements change. Built t...)

Date:10/14/2009

d expand as requirements change. Built to handle everything from single sites to multiple sites across an enterprise, TherapySource streamlines and automates clinical and financial processes, including scheduling, registration, clinical documentation and reporting. The automated coding and compliance features of TherapySource allow clinicians to spend less time on administrative processes and more time providing quality patient care.

"FOTO's patient outcomes survey efficiently provides the data needed for effectively communicating the effectiveness of the care provided to the treating therapist, the referring physician and the payer. Combining this data with TherapySource's clinical documentation creates the opportunity to make a direct link between therapy treatments and patient outcomes," said Ben Johnston, Jr., PT, FOTO's Chief Executive Officer.

"The partnership between TherapySource and FOTO creates an unbeatable product that provides payers with a complete picture of the effectiveness of treatments. This can directly affect the bottom line profitability of a clinic as payers will have little to dispute," said Ralph Riccardi, President and Chief Operating Officer of SourceMedical's therapy software division.

About FOTO
Started in 1992, FOTO pioneered the process of measuring patient self-reported outpatient outcomes. FOTO is the oldest independent system measuring outpatient outcomes. With over 2.5 million patients in their database, FOTO has the largest outcomes data set in outpatient therapy in the world! Experience, scientific acumen, and our large volume of data make FOTO the best at measuring Outpatient Rehabilitation Outcomes, which is our top priority.

About SourceMedical
SourceMedical is the leading provider of outpatient information solutions and services for ambulatory surgery centers, surgical hospitals and therapy clinics nationwide. With more than 4,000 satisfied customers, S
'/>"/>

Source: PRWeb Copyright©2009 Vocus, Inc. All rights reserved

0 GOOD

Page: 1 2 3
Related biology technology :

1. Octapharma Aims to Expand U.S. Immune Globulin Therapy Portfolio
2. Topical erectile dysfunction therapy shows promise
3. STALLERGENES: Immunotherapy Tablet Containing Recombinant Allergen (rBet v 1) of Birch Pollen: Positive Results for a Phase IIb/III Trial
4. Novexel Presents 16 Posters and one Slide Presentation at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Meeting in San Francisco
5. Dont Wait to Innovate: Future Pharmaceuticals Magazine Releases Its Issue on Innovation in IT, Cell-Based Therapy and Supply Chains
6. Adamas Pharmaceuticals to Present Data on Triple Combination Antiviral Drug Therapy for Drug-Resistant Influenza at 2009 ICAAC Annual Meeting
7. Cardio3 BioSciences Presents Update on C-Cure(R) Second Generation Stem Cell Therapy for Heart Failure at European Society of Cardiology Congress
8. Bioheart Strengthens Executive Team in Order to Accelerate Business Plan and Enhance Its Position in the Cardiovascular Stem Cell Therapy Industry
9. Abbott Expands XIENCE V(R) USA Trial to Enroll Patients into Landmark Dual Anti-Platelet Therapy (DAPT) Trial
10. Merck/Schering-Ploughs Zetia and Vytorin Have Lost Substantial Patient Share in Second- and Third-Line Therapy Since Last Years Analysis of Dyslipidemia
11. McKesson Expands Pharmacy Automation Product Portfolio to Include I.V. Therapy